You just read:

Omthera Pharmaceuticals Initiates Pivotal Phase III EVOLVE Trial for Epanova™ in Patients with Very High Triglycerides

News provided by

Omthera Pharmaceuticals, Inc.

Mar 14, 2011, 08:35 ET